Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Chitosan–hydroxyapatite biocomposites are promising for tissue engineering due to their safety and ability to support healing.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

A woman with lupus had blood cell destruction, treated successfully with medication.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

The HATMSC1 cell line from fat tissue can produce helpful factors for regenerative and immune therapies.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

The study showed that brown planaria can be used to cheaply test if local plants can stop cell growth.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Matriptase is crucial for skin, hair, and immune cell health, and its imbalance can lead to cancer.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.